on 31 Aug 2021
Last Applicant/ Owned by
In den Dauen 6a
Bonn
DE
53117
Serial Number
88278750 filed on 28th Jan 2019
Registration Number
6466029 registered on 31st Aug 2021
Correspondent Address
LEIGH ANN LINDQUIST
Filing Basis
1. intent to use
Disclaimer
NO DATA
Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties Chemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal Read More
Chemical, biological, biochemical and biotechnological products and preparations, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof for laboratory or research use and manufacturing use
Chemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof; diagnostic preparations for medical and veterinary use; medicinal preparations, pharmaceutical preparations and pharmaceutical substances for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; vaccines; adjuvants, carriers for active ingredients, drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents for medical use in humans or animals; biological implants comprising active ingredients; drug delivery systems consisting of proteins in the form of capsids or particles; drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents
Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties
Scientific research and development for others, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development as well as biotechnological services with regard to manufacturing pharmaceutical preparations, active substance carriers, active substance transport systems, drug delivery systems and active substance implants for use on humans or animals, for others; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for others
No 88278750
No Service Mark
No S24050
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Apr 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
26th Apr 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
26th Apr 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
26th Apr 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
26th Apr 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
31st Aug 2021 | REGISTERED-PRINCIPAL REGISTER |
27th Jul 2021 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
22nd Jul 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
01st Jul 2021 | NOTICE OF ALLOWANCE CANCELLED |
01st Jul 2021 | TEAS DELETE 1(B) BASIS RECEIVED |